Gyre Therapeutics, Inc. (GYRE) Earnings
|
Expand Research on GYRE
| Next EPS Date | 8/18/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -80.7% | Revenue Growth Rate | -1.2% |
| Average % Move 1-Wk after EPS | -2.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/26  |
Q226 | N/A | -$0.06 | N/A | N/A | $26.49M | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | -$0.10 | -$0.07 | -$0.03 | $22.5M | $37.05M | N/A |  | | Details | |
| 3/12/26 |
Q425 | -$0.02 | $0.05 | -$0.07 | $37.2M | $38.05M | N/A | | | Details | |
| 11/7/25 |
Q325 | $0.03 | $0.05 | -$0.02 | $30.56M | $33.55M | N/A | | | Details | |
| 8/11/25 |
Q225 | $0.00 | $0.02 | -$0.02 | $26.8M | $28.7M | N/A | | | Details | |
| 5/9/25 |
Q125 | $0.00 | $0.03 | -$0.03 | $22.1M | $24.5M | N/A | | | Details | |
| 3/17/25 |
Q125 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/17/25 | Q424 | $0.00 | $0.00 | $0.00 | $27.87M | N/A | N/A | | | Details |
